Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy on beta-cell Function and Glycemic Remission Rate in Newly Diagnosed Type 2 Diabetic Patients
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Exenatide (Primary) ; Insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Sep 2016 Primary endpoint of glycemic remission rate has been met, according to results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.
- 16 Sep 2016 Results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes
- 05 Feb 2013 New trial record